Nathan Jetter, MD
Dermatology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Jetter’s office at (650) 934-7676 to ask if they take your plan before you enroll.
California Medical Board record
Licence A180863 · Current
Licensed to practise in California · since 2022 · expires 2028-07-31 · University of Illinois College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$111,390
Pharmacies billed $111,390 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 437) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
349 generic and 88 brand-name prescriptions · $111,390 in drug cost · 14 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Calcipotriene | 47 | $3,739 | $80 |
| Fluorouracil | 83 | $3,223 | $39 |
| Tacrolimus | 30 | $2,359 | $79 |
| Desoximetasone | 38 | $1,511 | $40 |
| Mometasone Furoate | 35 | $1,400 | $40 |
See all 8 drugs
| Calcipotriene | 47 | $3,739 | $80 |
| Fluorouracil | 83 | $3,223 | $39 |
| Tacrolimus | 30 | $2,359 | $79 |
| Desoximetasone | 38 | $1,511 | $40 |
| Mometasone Furoate | 35 | $1,400 | $40 |
| Fluocinonide | 17 | $435 | $26 |
| Gentamicin Sulfate | 11 | $427 | $39 |
| Ketoconazole | 25 | $426 | $17 |
Year by year
| 2024 | 437 | 208 | 0% (0) | 20% | $111,390 |
| 2023 | 304 | 147 | 0% (0) | 6% | $31,340 |
| 2022 | 122 | 54 | 0% (0) | 11% | $58,099 |
| 2021 | 163 | 67 | 0% (0) | 15% | $28,453 |
| 2020 | 412 | 104 | 0% (0) | 17% | $258,826 |
| 2019 | 278 | 101 | None | 13% | $84,257 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Tacrolimus | 16 | $5,588 | $349 |
| Fluorouracil | 24 | $3,821 | $159 |
| Calcipotriene | 11 | $1,695 | $154 |
| Clobetasol Propionate | 19 | $1,205 | $63 |
| Fluocinonide | 18 | $1,188 | $66 |
| Mometasone Furoate | 26 | $788 | $30 |
| Desoximetasone | 12 | $744 | $62 |
| Ketoconazole | 23 | $617 | $27 |
| Doxycycline Hyclate | 17 | $536 | $32 |
| Triamcinolone Acetonide | 26 | $434 | $17 |
2022: 3 drugs
| Fluocinonide | 20 | $1,595 | $80 |
| Triamcinolone Acetonide | 14 | $412 | $29 |
| Ketoconazole | 20 | $410 | $21 |
2021: 4 drugs
| Fluocinonide | 14 | $1,563 | $112 |
| Doxycycline Hyclate | 13 | $1,004 | $77 |
| Ketoconazole | 14 | $240 | $17 |
| Triamcinolone Acetonide | 15 | $178 | $12 |
2020: 12 drugs
| Humira | 18 | $98,501 | $5,472 |
| Calcipotriene-Betamethasone Dp | 12 | $6,453 | $538 |
| Doxycycline Hyclate | 38 | $2,768 | $73 |
| Tacrolimus | 11 | $2,141 | $195 |
| Fluocinonide | 17 | $2,104 | $124 |
| Halobetasol Propionate | 19 | $1,819 | $96 |
| Calcipotriene | 16 | $1,455 | $91 |
| Mycophenolate Mofetil | 13 | $1,056 | $81 |
| Triamcinolone Acetonide | 50 | $978 | $20 |
| Ketoconazole | 30 | $636 | $21 |
| Hydrocortisone | 14 | $339 | $24 |
| Prednisone | 16 | $132 | $8 |
2019: 4 drugs
| Doxycycline Hyclate | 18 | $1,533 | $85 |
| Dapsone | 12 | $535 | $45 |
| Triamcinolone Acetonide | 30 | $446 | $15 |
| Prednisone | 29 | $239 | $8 |
Money from drug and device companies
$191 in 2025
| 2025 | 3 | 4 | None | $191 |
| 2024 | 2 | 3 | None | $232 |
| 2023 | 2 | 2 | None | $206 |
| 2022 | 3 | 3 | None | $149 |
| 2021 | 4 | 5 | None | $411 |
| 2020 | 2 | 8 | None | $207 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Regeneron Healthcare Solutions | Dupixent | $125 | 1 payment
|
| Amgen | Otezla | $40 | 2 payments
|
| Abbvie | Rinvoq | $26 | 1 payment
|
See all 4 published payments
| Amgen | Meals · 2025-10-29 | Otezla | $15 |
| Abbvie | Meals · 2025-09-24 | Rinvoq | $26 |
| Amgen | Meals · 2025-07-30 | Otezla | $25 |
| Regeneron Healthcare Solutions | Meals · 2025-05-10 | Dupixent | $125 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $232
| Lilly USA | Olumiant | $119 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $113 | 2 payments
|
2023: $206
| Abbvie | Rinvoq | $125 | 1 payment
|
| Pfizer | Cibinqo | $81 | 1 payment
|
2022: $149
| Regeneron Healthcare Solutions | Dupixent | $112 | 1 payment
|
| Lilly USA | Taltz | $22 | 1 payment
|
| Biofrontera | Ameluz | $15 | 1 payment
|
2021: $411
| AbbVie | Skyrizi | $120 | 2 payments
|
| Genzyme | Dupixent | $113 | 1 payment
|
| Ucb | None | $99 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $80 | 1 payment
|
2020: $207
| AbbVie | Humira | $164 | 6 payments
|
| Lilly USA | Taltz | $42 | 2 payments
|
Professional record
- NPI
- 1528564994
- Licence
- CA A180863California A180863: Current · expires 2028-07-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2018-04-03
- NPI last updated
- 2023-12-11
- NPI record certified
- 2023-12-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.